Is Carcinoembryonic Antigen the Holy Grail for Pancreatic Cyst Risk Stratification?

Is Carcinoembryonic Antigen the Holy Grail for Pancreatic Cyst Risk Stratification? Clin Endosc. 2021 Jan 25;: Authors: Bazarbashi AN, Lee LS PMID: 33486917 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33486917?dopt=Abstract

Source: Clinical Endoscopy - January 27, 2021 Category: Gastroenterology Tags: Clin Endosc Source Type: research

More News: Cancer & Oncology | Endoscopy | Gastroenterology | Pancreas